Apply for batch release of Sera as a veterinary medicinal product
Source: BUS Rheinland-PfalzBefore you can make an immunological veterinary medicinal product batch available for the German market, it must be tested and approved. State batch testing for immunological veterinary medicinal products is carried out by the Paul Ehrlich Institute (PEI).
The immunological veterinary medicinal products that require batch release include
- Sera
- vaccines
- immunomodulators
- Tuberculins
How are the sera checked?
The PEI reviews your submitted batch documentation (Official Batch Protocol Review, OBPR) on the basis of the EU administrative procedure for batch verification of immunological veterinary medicinal products in accordance with Article 128 of Regulation (EU) 2019/6.
If your batch meets the criteria laid down in the marketing authorization of your medicinal product, you will receive a national release notice and/or an EU certificate, if requested, by post from the PEI or you can retrieve both in PEI-C Rebuild.
What European standards are there?
Batch testing is regulated uniformly in the member states of the European Union (EU) and in Norway, Liechtenstein, Iceland and Switzerland. It is carried out according to the rules of the Official Medicines Control Laboratories (OMCL).
These laboratories have joined together to form a network under the direction of the European Directorate for the Quality of Medicines (EDQM). The Paul-Ehrlich-Institut (PEI) is represented in the OMCL network as a state control laboratory.
If your batch has already been released by a laboratory in the OMCL network, it will be recognized and therefore also released more quickly in Germany. If you would like to distribute your batches from Germany to other countries in the OMCL network, you can apply for an EU certificate from the PEI for this purpose.